Company

Company	*Date*
Biocon sees oral insulin partner by march	24/11/2011
Transgene Biotek sells technology to German firm	24/11/2011
Gilead in $11bn Pharmasset deal	23/11/2011
Cos have funds for buybacks, but not worker	23/11/2011
Abbott, Dabur, GSK eye jagdale's enery drinks biz	23/11/2011
Shasun to raise `150 crore PE	23/11/2011
Strides gets NOD for cancer drug	11/10/2011
Dr. Reddu’s calls off deal to buy JBCPL’s Russia business	27/09/2011
Shasun to start operating vizag plant from june	27/09/2011
Pharma MNCs using India as guinea pigs	26/09/2011
Force pharma units cut production	24/09/2011
Sun named Pharma Company of the year	23/09/2011
Jubilant life in $70-m deal with US pharma company	15/09/2011
CSC Buys AppLabs for Undisclosed amount	15/09/2011
Gen-next boost to Cipla’s growth pill	14/09/2011
FDA Overhang Persists	14/09/2011
Wockhardt trims operations in France	13/09/2011
R&D award for Bliss Pharma	12/09/2011
Venus anti-cancer drug	12/09/2011
Lipitor peer set for November debut	09/09/2011
Wockhardt seeks legal go-ahead for danone deal	04/08/2011
Piramal bets on contract manufacturing OTC drugs	03/08/2011
Aurobindo Pharma eyes $2b business	02/08/2011
Pfizer may find it tough to stay ahead of pack as demand slows	02/08/2011
GenLife ties up with two japan nutraceutical makers	02/08/2011
Ranbaxy Shares Up on Settlement Talks	02/08/2011
Sun Pharma chief to invest in Israeli firm	02/08/2011
Lupin looks to acquire large Lat Am firm	02/08/2011
Aurobindo scouting for $100-200 m buyouts	02/08/2011
Lupin to market Eli Lilly’s diabetes drugs in india, Nepal	30/07/2011
Orchid Chemicals to invest Rs 200 cr on therapeutic products	30/07/2011
Sun Pharma stops contract manufacturing	30/07/2011
Merck to cut as many as 13000 jobs	30/07/2011
Onco Therapies gets USFDA nod for cancer drug	27/07/2011
Glenmark profit rises 23.2% to `210 crore	27/07/2011
Lupin inks two deals with Medicis	26/07/2011
Dr. Reddy's starts reorganisation of its R&D	22/07/2011
Lower licensing income drags Biocon Q1 profits	22/07/2011
Mixed bag from Dr. Reddy's	22/07/2011
Offshore generics sales push Dr. Reddy's net up 25%	21/07/2011
Glenmark gets FDA nod for anti-ulcer capsules	19/07/2011
Lupin denies it plans t sell Indian pharmaceutical unit	19/07/2011
Lupin Mulls Sale of its Indian Unit	19/07/2011
Ranbaxy Refusing Legal costs: Retailer	18/07/2011
Orchid Chemicals' drug gets USFDA nod	15/07/2011
Glenmark receives USFDA nod for generic Ursodiol tablets	14/07/2011
USFDA approval to enhance revenues, profits	14/07/2011
Venus launches painkiller injection	12/07/2011
Pfizer's reorganization has local impact	12/07/2011
Pharma majors focus on developing diabetes medicines	05/07/2011
Biopharm co celon labs plans to go global	29/06/2011
Jubilant inks pact with janssen Pharma	29/06/2011
Agreement between lupin & natco for cencer medicine	24/06/2011
Aurobindo clears all outstanding FCCBs for `600 cr	19/05/2011
Dr. Reddy’s enters pact with US co Oceana for Deflux	19/05/2011
DRL gets rights to sell distribute deflux in india	18/05/2011
DRL in deal with US firm	18/05/2011
DRL in deal with US pharma co	18/05/2011
Glenmark: On a new course	17/05/2011
Strong US drug pipeline to boost revenues	17/05/2011
Glenmark gets licensing deal boost shares surge	17/05/2011
US markets to drive growth for Dr. Reddy’s	16/05/2011
Uncertainty over generic Lipitor	15/05/2011
Aurobindo Pharma pins hope on early US FDA inspection	15/05/2011
Piramal to invest `500 cr in PE	14/05/2011
Shasun may start work on vizag plant this year	13/05/2011
Takeda offers $12 B for swiss drugs firm nycomed	13/05/2011
Divi's Labs scouts for buys in Europe, US	12/05/2011
M&A norms: Industry happy with concept, unhappy with construct	12/05/2011
Battke with USFDA offers little to cheer	11/05/2011
The push and pull in generic drugs	10/05/2011
Dr Reddy's joins race for Doktor mom	10/05/2011
Top exec in Ranbaxy M&A team resigns	09/05/2011
Lupin looks at more buyouts in Japan	07/05/2011
Ranbaxy shares fall on $ 1 bn payout news	06/05/2011
Cipla's margins hit by product mix and new unit costs	06/05/2011
Zenotech founder seeks to buy Daiichi stake for Rs. 300 cr	06/05/2011
Bio pharma sector invited for talks by planning commission	06/05/2011
India eyes $10b from biotech sector	05/05/2011
Biotech sector may miss 2015 growth target	0505/2011
Dabur buys Ajanta Pharma capsule brand	04/05/2011
Teva to acquire Cephalon for $6.8 billion	03/05/2011
GMP certificate must for Govt supply of medicines	03/05/2011
Biocon exits AxiCorp, sells stake to German promoters	29/04/2011
Dr. Reddy's to sell depression pill in US	25/04/2011
Small pharma units in MP face takeover bids.	23/04/2011
Indore drug unit was unauthorised	02/04/2011
Abbott-Solvay merger gets shareholders go-ahead	25/03/2011
Dr. Reddy's board okays bonus debentures	25/03/2011
Shasun puts loss from closure of cuddalore plant at Rs. 50 crore	25/03/2011
Pharma companies participated in nigeria exhibition	25/03/2011
Lupin grants 50,000 options to staff	22/03/2011
Zenotech chairman	22/03/2011
Jubilant life to set up new plant in Gujarat	09/03/2011
HSBC global cuts stake in Aurobindo Pharma	09/03/2011
How orchid bloomed after hospira deal	09/03/2011
Laboratorios to market panacea drug in europe	03/03/2011
Claris lifesciences declares Rs. 2 dividend	03/03/2011
Strides gets FDA nod for injection	02/03/2011
Piramal aims to grow OTC biz fivefold in 3 years	02/03/2011
Daiichi to buy Plexxikon for $805mn	02/03/2011
Ranbaxy to sell Daiichi sankyo's products in singapore	02/03/2011
A turnaround year	28/02/2011
Indore-based unit blacklisted for spwins iv supply in Rajasthan	28/02/2011
Aurobindo in a daze over FDA ban	25/02/2011
DRL slows down on diabetic drug	24/02/2011
DRL	22/02/2011
Sonofi-Aventis may buy branded generics	22/02/2011
Wockhardt formalises deal with US co Sheffield Bio	22/02/2011
GlaxoSmithKline Pharmaceutical	22/02/2011
Reckitt to Absorb Top Paras Executives	22/02/2011
Jubliant life sciences net profit at Rs. 44 cr.	15/02/2011
GSK Pharma pins hopes on new products	15/02/2011
Biocon to go for fresh oral insulin trials with new partner	24/01/2011
Jupiter Biosciences in talks to buy Swiss pharma co for $10 m	24/01/2011
Our key focus will be on foreign markets, including US, Europe	24/01/2011
After Dr. Reddu's, Wockhardt too to sell acidity drug Protonix in US	22/01/2011
For Biocon, oral insulin & Germany stay mysteries	22/01/2011
Generics will drive pharma growth	03/01/2011
Bicon trips on German rebate	21/01/2011
Regulatory our main challenge	21/01/2011
US to become Ranbaxy's biggest market	20/01/2011
Orchid Chemicals net profit surges on AIP biz growth on AIP biz growth	20/01/2011
Strides gets UFDA nod	19/01/2011
Glenmark unlikely to withdraw generic tarka drug from US	19/01/2011
Glenmark tanks 6% after US jury ruling on hypertendion drug	18/01/2011
ViiV seeks partners for HIV drug in India	18/01/2011
Picking up strength	17/01/2011
Zephyr Peacock to invest $5 m in Aizant	17/01/2011
Lupin's drug for arthritis gets US nod	15/01/2011
Natco junks US medicine retailing plan, sells front-end	15/01/2011
K&C Pharmacy exits Nicks drugs	15/01/2011
Glenmark gets FDA nod	14/01/2011
Glenmark US arm gets USFAD nod to sell GSK's malaria drug	14/01/2011
Biocon oral insulin seems to be coming up short	12/01/2011
Aurobindo to sell majority stake in chinese arm	12/01/2011
Aurobindo to divest stake in china arm	12/01/2011
Aurobindo may settle patent issue	11/01/2011
Parabolic Drugs unit on stream	07/01/2011
Merck-Ranbaxy drug deal called off	07/01/2011
Glaxo sets teeth on dental opening	06/01/2011
Lupin scouts for buys in Latin America	06/01/2011
Ties up with UK-based research organisation	06/01/2011
Japanese approval to elder Pharma's API plant at patalganga	06/01/2011
RPG life sciences launches dialysis drug	06/01/2011
Spectrum Pharma to make biosimilar of Roche's retuximab	06/01/2011
We are focused on bringing new products from our global portfolio	06/01/2011
Himalaya enters oral care	06/01/2011
Dishman eyes $20-25 million revenues from china API unit	05/01/2011
Natco seeks Pfizer nod for drug clone	05/01/2011
Pfizer's opportunity goes up in smoke	05/01/2011
Merck KGaA focuses on diabetes in India, lines up five products	05/01/2011
Dr Reddy's generic version of Lipitor hits Pfizer roadblock in US	05/01/2011
At Novartis, research chief's strategy is a winning formula	05/01/2011
We need time to grow organically	05/01/2011
DRL Ranbaxy scrips gain	04/01/2011
Dainippon Sumitomo Pharma Co. Ltd.	04/01/2011
Sujatha Biotech ties up with Kunnath Pharma	04/01/2011
With serdia rap, taxman puts pharma MNCs on notice	03/01/2011
Pharma companies are being respected for their quality	03/01/2011
CVS will buy Universal's Medicare arm for $1.25b	02/01/2011
Rallis India completes stake buy in Metahelix	01/01/2011